Breast cancer in pregnancy: Recommendations of an international consensus meeting

Frédéric Amant, Sarah Deckers, Kristel Van Calsteren, Sibylle Loibl, Michael Halaska, Lieselot Brepoels, Jos Beijnen, Fatima Cardoso, Oreste Gentilini, Lieven Lagae, Olivier Mir, Patrick Neven, Nelleke Ottevanger, Steven Pans, Fedro Peccatori, Roman Rouzier, Hans Jörg Senn, Henk Struikmans, Marie Rose Christiaens, David CameronAndreas Du Bois

Research output: Contribution to journalArticle

Abstract

Purpose: To provide guidance for clinicians about the diagnosis, staging and treatment of breast cancer occurring during an otherwise uncomplicated pregnancy. Methods: An international expert Panel convened to address a series of questions identified by a literature review and personal experience. Issues relating to the diagnosis and management of breast cancer after delivery were outside the scope. Results: There is a paucity of large and/or randomized studies. Based on cohort studies, case series and case reports, the recommendations represent the best available evidence, albeit of a lower grade than is optimal. Recommendations: In most circumstances, serious consideration should be given to the option of treating breast cancer whilst continuing with the pregnancy. Each woman should ideally be referred to a centre with sufficient expertise, given a clear explanation of treatment options. Most diagnostic and staging examinations can be performed adequately and safely during pregnancy. Treatment should however be adapted to the clinical presentation and the trimester of the pregnancy: surgery can be performed during all trimesters of pregnancy; radiotherapy can be considered during the first and second trimester but should be postponed during the third trimester; and standard chemotherapies can be used during the second and third trimester. Since neonatal morbidity mainly appears to be related to prematurity, delivery should not be induced before 37 weeks, if at all possible. Conclusions: The treatment of breast cancer in pregnancy should be executed by experienced specialists in a multidisciplinary setting and should adhere as closely as possible to standard protocols.

Original languageEnglish
Pages (from-to)3158-3168
Number of pages11
JournalEuropean Journal of Cancer
Volume46
Issue number18
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Breast Neoplasms
Pregnancy Trimesters
Pregnancy
Third Pregnancy Trimester
Second Pregnancy Trimester
First Pregnancy Trimester
Therapeutics
Cohort Studies
Radiotherapy
Morbidity
Drug Therapy

Keywords

  • Biological
  • Breast
  • Cancer
  • Chemotherapy
  • Consensus
  • Guideline
  • Pregnancy
  • Radiotherapy
  • Surgery

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Amant, F., Deckers, S., Van Calsteren, K., Loibl, S., Halaska, M., Brepoels, L., ... Du Bois, A. (2010). Breast cancer in pregnancy: Recommendations of an international consensus meeting. European Journal of Cancer, 46(18), 3158-3168. https://doi.org/10.1016/j.ejca.2010.09.010

Breast cancer in pregnancy : Recommendations of an international consensus meeting. / Amant, Frédéric; Deckers, Sarah; Van Calsteren, Kristel; Loibl, Sibylle; Halaska, Michael; Brepoels, Lieselot; Beijnen, Jos; Cardoso, Fatima; Gentilini, Oreste; Lagae, Lieven; Mir, Olivier; Neven, Patrick; Ottevanger, Nelleke; Pans, Steven; Peccatori, Fedro; Rouzier, Roman; Senn, Hans Jörg; Struikmans, Henk; Christiaens, Marie Rose; Cameron, David; Du Bois, Andreas.

In: European Journal of Cancer, Vol. 46, No. 18, 12.2010, p. 3158-3168.

Research output: Contribution to journalArticle

Amant, F, Deckers, S, Van Calsteren, K, Loibl, S, Halaska, M, Brepoels, L, Beijnen, J, Cardoso, F, Gentilini, O, Lagae, L, Mir, O, Neven, P, Ottevanger, N, Pans, S, Peccatori, F, Rouzier, R, Senn, HJ, Struikmans, H, Christiaens, MR, Cameron, D & Du Bois, A 2010, 'Breast cancer in pregnancy: Recommendations of an international consensus meeting', European Journal of Cancer, vol. 46, no. 18, pp. 3158-3168. https://doi.org/10.1016/j.ejca.2010.09.010
Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L et al. Breast cancer in pregnancy: Recommendations of an international consensus meeting. European Journal of Cancer. 2010 Dec;46(18):3158-3168. https://doi.org/10.1016/j.ejca.2010.09.010
Amant, Frédéric ; Deckers, Sarah ; Van Calsteren, Kristel ; Loibl, Sibylle ; Halaska, Michael ; Brepoels, Lieselot ; Beijnen, Jos ; Cardoso, Fatima ; Gentilini, Oreste ; Lagae, Lieven ; Mir, Olivier ; Neven, Patrick ; Ottevanger, Nelleke ; Pans, Steven ; Peccatori, Fedro ; Rouzier, Roman ; Senn, Hans Jörg ; Struikmans, Henk ; Christiaens, Marie Rose ; Cameron, David ; Du Bois, Andreas. / Breast cancer in pregnancy : Recommendations of an international consensus meeting. In: European Journal of Cancer. 2010 ; Vol. 46, No. 18. pp. 3158-3168.
@article{91848489a6994b4c847e323dd8b70d7e,
title = "Breast cancer in pregnancy: Recommendations of an international consensus meeting",
abstract = "Purpose: To provide guidance for clinicians about the diagnosis, staging and treatment of breast cancer occurring during an otherwise uncomplicated pregnancy. Methods: An international expert Panel convened to address a series of questions identified by a literature review and personal experience. Issues relating to the diagnosis and management of breast cancer after delivery were outside the scope. Results: There is a paucity of large and/or randomized studies. Based on cohort studies, case series and case reports, the recommendations represent the best available evidence, albeit of a lower grade than is optimal. Recommendations: In most circumstances, serious consideration should be given to the option of treating breast cancer whilst continuing with the pregnancy. Each woman should ideally be referred to a centre with sufficient expertise, given a clear explanation of treatment options. Most diagnostic and staging examinations can be performed adequately and safely during pregnancy. Treatment should however be adapted to the clinical presentation and the trimester of the pregnancy: surgery can be performed during all trimesters of pregnancy; radiotherapy can be considered during the first and second trimester but should be postponed during the third trimester; and standard chemotherapies can be used during the second and third trimester. Since neonatal morbidity mainly appears to be related to prematurity, delivery should not be induced before 37 weeks, if at all possible. Conclusions: The treatment of breast cancer in pregnancy should be executed by experienced specialists in a multidisciplinary setting and should adhere as closely as possible to standard protocols.",
keywords = "Biological, Breast, Cancer, Chemotherapy, Consensus, Guideline, Pregnancy, Radiotherapy, Surgery",
author = "Fr{\'e}d{\'e}ric Amant and Sarah Deckers and {Van Calsteren}, Kristel and Sibylle Loibl and Michael Halaska and Lieselot Brepoels and Jos Beijnen and Fatima Cardoso and Oreste Gentilini and Lieven Lagae and Olivier Mir and Patrick Neven and Nelleke Ottevanger and Steven Pans and Fedro Peccatori and Roman Rouzier and Senn, {Hans J{\"o}rg} and Henk Struikmans and Christiaens, {Marie Rose} and David Cameron and {Du Bois}, Andreas",
year = "2010",
month = "12",
doi = "10.1016/j.ejca.2010.09.010",
language = "English",
volume = "46",
pages = "3158--3168",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "18",

}

TY - JOUR

T1 - Breast cancer in pregnancy

T2 - Recommendations of an international consensus meeting

AU - Amant, Frédéric

AU - Deckers, Sarah

AU - Van Calsteren, Kristel

AU - Loibl, Sibylle

AU - Halaska, Michael

AU - Brepoels, Lieselot

AU - Beijnen, Jos

AU - Cardoso, Fatima

AU - Gentilini, Oreste

AU - Lagae, Lieven

AU - Mir, Olivier

AU - Neven, Patrick

AU - Ottevanger, Nelleke

AU - Pans, Steven

AU - Peccatori, Fedro

AU - Rouzier, Roman

AU - Senn, Hans Jörg

AU - Struikmans, Henk

AU - Christiaens, Marie Rose

AU - Cameron, David

AU - Du Bois, Andreas

PY - 2010/12

Y1 - 2010/12

N2 - Purpose: To provide guidance for clinicians about the diagnosis, staging and treatment of breast cancer occurring during an otherwise uncomplicated pregnancy. Methods: An international expert Panel convened to address a series of questions identified by a literature review and personal experience. Issues relating to the diagnosis and management of breast cancer after delivery were outside the scope. Results: There is a paucity of large and/or randomized studies. Based on cohort studies, case series and case reports, the recommendations represent the best available evidence, albeit of a lower grade than is optimal. Recommendations: In most circumstances, serious consideration should be given to the option of treating breast cancer whilst continuing with the pregnancy. Each woman should ideally be referred to a centre with sufficient expertise, given a clear explanation of treatment options. Most diagnostic and staging examinations can be performed adequately and safely during pregnancy. Treatment should however be adapted to the clinical presentation and the trimester of the pregnancy: surgery can be performed during all trimesters of pregnancy; radiotherapy can be considered during the first and second trimester but should be postponed during the third trimester; and standard chemotherapies can be used during the second and third trimester. Since neonatal morbidity mainly appears to be related to prematurity, delivery should not be induced before 37 weeks, if at all possible. Conclusions: The treatment of breast cancer in pregnancy should be executed by experienced specialists in a multidisciplinary setting and should adhere as closely as possible to standard protocols.

AB - Purpose: To provide guidance for clinicians about the diagnosis, staging and treatment of breast cancer occurring during an otherwise uncomplicated pregnancy. Methods: An international expert Panel convened to address a series of questions identified by a literature review and personal experience. Issues relating to the diagnosis and management of breast cancer after delivery were outside the scope. Results: There is a paucity of large and/or randomized studies. Based on cohort studies, case series and case reports, the recommendations represent the best available evidence, albeit of a lower grade than is optimal. Recommendations: In most circumstances, serious consideration should be given to the option of treating breast cancer whilst continuing with the pregnancy. Each woman should ideally be referred to a centre with sufficient expertise, given a clear explanation of treatment options. Most diagnostic and staging examinations can be performed adequately and safely during pregnancy. Treatment should however be adapted to the clinical presentation and the trimester of the pregnancy: surgery can be performed during all trimesters of pregnancy; radiotherapy can be considered during the first and second trimester but should be postponed during the third trimester; and standard chemotherapies can be used during the second and third trimester. Since neonatal morbidity mainly appears to be related to prematurity, delivery should not be induced before 37 weeks, if at all possible. Conclusions: The treatment of breast cancer in pregnancy should be executed by experienced specialists in a multidisciplinary setting and should adhere as closely as possible to standard protocols.

KW - Biological

KW - Breast

KW - Cancer

KW - Chemotherapy

KW - Consensus

KW - Guideline

KW - Pregnancy

KW - Radiotherapy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=78649634589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649634589&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2010.09.010

DO - 10.1016/j.ejca.2010.09.010

M3 - Article

C2 - 20932740

AN - SCOPUS:78649634589

VL - 46

SP - 3158

EP - 3168

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 18

ER -